Quarterly report pursuant to Section 13 or 15(d)

Debt (Details)

v3.20.2
Debt (Details)
1 Months Ended
Jun. 05, 2020
$ / shares
shares
Jan. 22, 2020
USD ($)
lender
day
note
$ / shares
Mar. 06, 2019
USD ($)
agreement
$ / shares
shares
Nov. 05, 2018
USD ($)
$ / shares
shares
Mar. 31, 2019
USD ($)
agreement
Jul. 31, 2020
USD ($)
Jun. 08, 2020
shares
Apr. 30, 2020
USD ($)
Debt Instrument [Line Items]                
Proceeds from issuance or sale of equity   $ 10,000,000            
Net proceeds from convertible debt   16,000,000            
Number of loan agreements | agreement     2   2      
Cooperman Warrants                
Debt Instrument [Line Items]                
Number of securities called by warrants or rights (in shares) | shares             192,049  
Warrant | Cooperman Warrants                
Debt Instrument [Line Items]                
Common stock issued for warrants exercised for cash (in shares) | shares 100,000              
Loans Payable                
Debt Instrument [Line Items]                
Write off of unamortized original issue discount and debt issuance costs   182,000            
Loan Agreements                
Debt Instrument [Line Items]                
Debt instrument, term     5 years          
Stock issued during period, conversion of convertible securities (in shares) | shares     100,000          
Warrants granted, exercise price (in dollars per share) | $ / shares     $ 6.00          
Loan Agreements | Cooperman Warrants                
Debt Instrument [Line Items]                
Warrants granted, exercise price (in dollars per share) | $ / shares $ 5.70   $ 6.00          
Loan Agreements | Warrant                
Debt Instrument [Line Items]                
Number of warrant agreements | agreement     2          
Warrants issued as part of senior secured term loans     $ 360,516          
Closing costs treated as debt discounts     33,693          
Revolving Credit Facility                
Debt Instrument [Line Items]                
Line of credit, maximum borrowing capacity     5,000,000 $ 5,000,000        
Debt instrument, term       3 years        
Leon and Toby Cooperman Family Foundation | Loan Agreements                
Debt Instrument [Line Items]                
Proceeds from issuance or sale of equity     $ 10,000,000   $ 10,000,000      
Debt instrument, interest rate, stated percentage     12.00%          
Debt instrument, extension period     12 months          
One-time extension fee (as a percent)         1.00%      
Proceeds from issuance of secured debt     $ 5,000,000          
One-time extension fee (as a percent)     1.00%          
Convertible Notes | Convertible Notes Payable                
Debt Instrument [Line Items]                
Face value of loan   $ 5,000,000            
Number of lenders | lender   2            
Number of notes | note   2            
Conversion period after issuance date   6 months            
Conversion price (in dollars per share) | $ / shares   $ 7.15            
Average closing price of common stock (in dollars per share) | $ / shares   $ 10.725            
Consecutive trading day period | day   20            
Debt instrument, term   3 years            
Debt instrument, interest rate, stated percentage   7.00%            
Debt instrument, extension period   1 year            
Extension fee per note   $ 50,000            
Total extension fee   100,000            
Payments to cover taxes   40,400            
Convertible Notes | Revolving Credit Facility                
Debt Instrument [Line Items]                
Line of credit, maximum borrowing capacity       $ 5,000,000        
Beneficial conversion feature on convertible debt   $ 1,692,309            
Credit Facility Agreement | Revolving Credit Facility                
Debt Instrument [Line Items]                
Line of credit, maximum borrowing capacity       $ 5,000,000        
Interest rate of debt (as a percent)       12.00%        
One-time upfront facility fee       $ 100,000        
One-time extension fee (as a percent)       2.00%        
Number of securities called by warrants or rights (in shares) | shares       92,049        
Warrant term       5 years        
Exercise price of warrants (in dollars per share) | $ / shares       $ 5.85        
Fair value of warrants outstanding       $ 255,071        
Unamortized costs           $ 43,056   $ 182,418
Credit Facility Agreement | Revolving Credit Facility | Cooperman Warrants                
Debt Instrument [Line Items]                
Exercise price of warrants (in dollars per share) | $ / shares $ 5.56     $ 5.85